BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 41176)

  • 1. The development of anti-allergic drugs.
    Orr TS
    Monogr Allergy; 1979; 14():293-8. PubMed ID: 41176
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-allergic properties of a new coumarin compound (BM 15,100) [proceedings].
    Roesch A; Roesch E
    Br J Pharmacol; 1976 Jul; 57(3):438P. PubMed ID: 10033
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiallergic activity of picumast dihydrochloride in several animal species.
    Roesch A; Schaumann W; Wilhelms OH
    Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of allergic reactions by a novel phenanthroline ICI 74,917.
    Evans DP; Gilman DJ; Thomson DS; Waring WS
    Nature; 1974 Aug; 250(467):592-3. PubMed ID: 4136035
    [No Abstract]   [Full Text] [Related]  

  • 6. Picumast dihydrochloride (Auteral), a new anti-allergic inhibitor of mediator release and action.
    Wilhelms OH; Roesch A; Schaumann W
    Agents Actions Suppl; 1991; 34():335-49. PubMed ID: 1686528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
    Gutiérrez B; Dordal A; Fort M; Galicia J; Farré AJ
    Methods Find Exp Clin Pharmacol; 1996; 18(6):397-406. PubMed ID: 8892269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunopharmacological studies of anti-hypersensitivity agents].
    Koda A
    Nihon Rinsho; 1981 Apr; 39(4):1801-6. PubMed ID: 6171654
    [No Abstract]   [Full Text] [Related]  

  • 9. Nature and modes of action of disodium cromoglycate (Lomudal).
    Cox JS; Altounyan RE
    Respiration; 1970; 27():Suppl:292-309. PubMed ID: 4101895
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of a new orally active antiallergic: pyrido[1,2-a]pyrimidine, ucb L140 (CHINOIN 1045) in rats.
    De Vos C; Dessy F; Hermecz I; Meszaros Z; Breining T
    Int Arch Allergy Appl Immunol; 1982; 67(4):362-8. PubMed ID: 6175586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo.
    Casey FB; Abboa-Offei BE; Marretta J
    J Pharmacol Exp Ther; 1980 Jun; 213(3):432-6. PubMed ID: 7205610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of disodium cromoglycate on various types of anaphylactic reaction in the guinea pig.
    Taylor WA; Roitt IM
    Int Arch Allergy Appl Immunol; 1973; 45(6):795-807. PubMed ID: 4128404
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunopharmacologic properties of WY-16, 922, a new orally effective antiallergic agent.
    Rosenthale ME; Begany AJ; Dervinis A; Sellstedt J; Guinosso C; Gluckman MI
    J Pharmacol Exp Ther; 1976 Jun; 197(3):725-33. PubMed ID: 58988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tecastemizole on pulmonary and cutaneous allergic inflammatory responses.
    Lever R; Hefni A; Moffatt JD; Paul W; Page CP
    Clin Exp Allergy; 2007 Jun; 37(6):909-17. PubMed ID: 17517105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
    Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs used in allergic states and their mode of action.
    Eisner JW
    Semin Drug Treat; 1973; 2(4):367-77. PubMed ID: 4122217
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of allergic eye disease.
    Bartlett JD
    J Am Optom Assoc; 1990 Jun; 61(6 Suppl):S23-31. PubMed ID: 1972944
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of various anti-allergic agents on IgE-mediated anaphylactic alterations of pulmonary function in rats.
    Menassé R; Ferrini PG; Niderhauser U; Szeszak J
    Monogr Allergy; 1979; 14():126-9. PubMed ID: 116122
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cromoglycate disodium in vasomotoric rhinopathies, not specifically allergic, of the perennial type].
    Volterrani O
    Folia Allergol (Roma); 1972; 19(2):171-3. PubMed ID: 4402876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.